Canada markets close in 4 hours 25 minutes

RVL Pharmaceuticals plc (O1P.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
0.00300.0000 (0.00%)
At close: 08:31AM CEST
Currency in EUR

Valuation Measures4

Market Cap (intraday) 1.65M
Enterprise Value 38.48M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.01
Price/Book (mrq)0.02
Enterprise Value/Revenue 1.04
Enterprise Value/EBITDA -0.68

Trading Information

Stock Price History

Beta (5Y Monthly) 0.75
52-Week Change 3-99.80%
S&P500 52-Week Change 323.10%
52 Week High 31.4900
52 Week Low 30.0030
50-Day Moving Average 30.0812
200-Day Moving Average 30.6154

Share Statistics

Avg Vol (3 month) 312.35k
Avg Vol (10 day) 346.82k
Shares Outstanding 5111.41M
Implied Shares Outstanding 6631.91M
Float 886.21M
% Held by Insiders 13.68%
% Held by Institutions 19.72%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends Dec 31, 2022
Most Recent Quarter (mrq)Jun 30, 2023

Profitability

Profit Margin -184.91%
Operating Margin (ttm)-98.34%

Management Effectiveness

Return on Assets (ttm)-23.65%
Return on Equity (ttm)-182.44%

Income Statement

Revenue (ttm)36.92M
Revenue Per Share (ttm)0.38
Quarterly Revenue Growth (yoy)-2.20%
Gross Profit (ttm)N/A
EBITDA -39.39M
Net Income Avi to Common (ttm)-68.27M
Diluted EPS (ttm)-0.6700
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)19.16M
Total Cash Per Share (mrq)0.19
Total Debt (mrq)58.15M
Total Debt/Equity (mrq)356.16%
Current Ratio (mrq)0.38
Book Value Per Share (mrq)0.16

Cash Flow Statement

Operating Cash Flow (ttm)-44.41M
Levered Free Cash Flow (ttm)-25.56M